CN

Imatinib Mesylate Product DMF Has Successfully Passed the US FDA Scientific Review

source:TH author:TH Publication time:2018-11-01 browse:331

September 29, 2018, Tai Heng received official letter from the US FDA,which is in reference to our DMF(#024838)for Imatinib Mesylate. The letter indicated that FDA had completed the full scientific review of this DMF and had found the DMF to be adequate to support an ANDA submission. Tai Heng commites that if there are any future changes to the DMF, we will promptly report to the FDA and inform our customers per 21 CFR 314.420(c).





永利网投赌博平台-澳门线上赌博网站-澳门葡京赌场网址-

执行时间:0.1019721031189秒 查询数据库10次 内存使用:1.067 mb - 256.945 kb = 836.133 kb 当前模式:developer